Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Patheon Holdings II B.V., a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in the Netherlands (NL). Founded in 1974, the company has established itself as a leader in contract development and manufacturing services (CDMO), catering to a diverse range of clients across Europe and North America.
Specialising in drug development, clinical trial services, and commercial manufacturing, Patheon is renowned for its innovative solutions that streamline the drug production process. The company’s commitment to quality and efficiency has positioned it as a trusted partner for pharmaceutical companies seeking to bring their products to market swiftly and effectively.
With a strong market presence and a reputation for excellence, Patheon Holdings II B.V. continues to achieve significant milestones, reinforcing its status as a key contributor to the global healthcare landscape.
+77 vs industry average
Patheon Holdings Ii B.V.’s score of 93 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
N-Fertiliser is among the most carbon-intensive industries
The N-Fertiliser industry has reduced its overall emissions by 9% since 2018
No reported emissions data is available for Patheon Holdings Ii B.V. yet.
Patheon Holdings II B.V., headquartered in the Netherlands (NL), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of DSM-Firmenich AG, which may influence its climate commitments and performance metrics.
While there are no direct emissions targets or reduction initiatives reported for Patheon Holdings II B.V., it inherits climate commitments and performance data from its parent company, DSM-Firmenich AG. This includes participation in various sustainability initiatives such as the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from DSM-Firmenich AG.
As a subsidiary, Patheon Holdings II B.V. aligns with the broader climate strategies of DSM-Firmenich AG, which are designed to address carbon emissions and promote sustainability within the industry. However, specific reduction targets or achievements for Patheon Holdings II B.V. have not been disclosed.
In summary, while Patheon Holdings II B.V. does not provide its own emissions data or reduction targets, it is positioned within a corporate structure that prioritises climate action through its parent company, DSM-Firmenich AG.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Patheon Holdings Ii B.V. yet.
No scope 3 category breakdown has been disclosed yet.


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more